Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Geriatric Oncology|July 3, 2021
Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)Futa Koga, Yasunori Kawaguchi, Mototsugu Shimokawa, et al.
International Journal of Clinical Oncology|May 23, 2026
SCRUM-Japan MONSTAR3 hematology cohort: a nationwide multi-omics integrated platform for next-generation precision medicine in hematologic malignanciesKensuke Matsuda, Junichiro Yuda, Ryo Yoshimaru, et al.
Journal of Gastroenterology|May 25, 2026
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancerTaro Shibuki, Celine Hoyek, Ryne Ramaker, et al.
Neuroendocrinology|September 26, 2025
Multicenter Retrospective Study of Efficacy of Systemic Therapy in Patients with Neuroendocrine Tumor Grade 3 (JOSC-2001)Hiroyuki Okuyama, Taro Shibuki, Naohiro Okano, et al.
Cancer Science|June 2, 2025
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 StudyTadayoshi Hashimoto, Naoko Iida, Yoshiaki Nakamura, et al.
International Journal of Clinical Oncology|July 27, 2026
AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTCTadayoshi Hashimoto, Taro Shibuki, Takao Fujisawa, et al.
Therapeutic Advances in Medical Oncology|February 24, 2025
Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)Tomonori Araki, Kohei Hayashi, Mototsugu Shimokawa, et al.
BJC Reports|November 8, 2024
Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumorsTadayoshi Hashimoto, Yoshiaki Nakamura, Yoshito Komatsu, et al.
Asia-Pacific Journal of Clinical Oncology|November 4, 2025
Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Older Versus Younger Patients With Unresectable Pancreatic Cancer: The Multicenter NAPOLEON-2 StudyAtsuko Kakihara, Shigeyuki Takeshita, Mototsugu Shimokawa, et al.
BMC Cancer|October 22, 2025
Impact of biliary drainage for unresectable pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid: retrospective results from the NAPOLEON-2 studyKazuo Nishikawa, Taiga Otsuka, Mototsugu Shimokawa, et al.
Pageof 5